StockData
Tvardi Therapeutics, Inc. logo

Tvardi Therapeutics, Inc. (TVRD) stock

TVRDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.04+0.03 (+2.97%)

Close on Nov 18, 2026Market cap $13.87MP/E –Yield 0.00%

Tvardi Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Tvardi Therapeutics's price to sales ratio was 5.2× on Jul 31, 2025, against 3.4× a year earlier. Over the last 5 years it ranged from 2.5× to 95.7×, with a median of 14.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Jul 31, 20255.2×−4.4
2024Dec 31, 20249.7×+3.9
2023Dec 29, 20235.7×−38.2
2022Dec 30, 202243.9×+30.3
2021Dec 31, 202113.7×−63.7
2020Dec 31, 202077.4×−30.5
2019Dec 31, 2019107.9×−118.6
2016Oct 31, 2016226.5×−65.5
2015Dec 31, 2015292.0×+81.5
2014Dec 31, 2014210.5×–

More Tvardi Therapeutics figures

See a number that looks wrong?